Is the Grail IPO Worth Investing In?

The S&P 500 lost 31% in March. The IPO market saw a huge slump in the ensuing months. There was little confidence in the public market. But certain players in the health sector did not hurt the same. In fact, tech and health stocks seemed more stable with a work-from-home trend and a push for coronavirus vaccines. While these sectors got a lift from this year's events, they didn't need it. There will always be companies innovating in tech and health, despite any lockdown scenario. Grail is one of those companies. That's why, in a year of scant IPOs, this innovative biotech is one of a handful that have come out announcing their IPO underway. The post Is the Grail IPO Worth Investing In? appeared first on Money Morning - We Make Investing Profitable . Read more... Tags: IPOs To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and visitors become smarter, more confident investors. Disclaimer: © 2020 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.